本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ovid Therapeutics Inc.

2.34
-0.1250-5.08%
成交量:163.63万
成交额:386.01万
市值:3.53亿
市盈率:-10.04
高:2.45
开:2.42
低:2.30
收:2.46
52周最高:2.72
52周最低:0.2425
股本:1.51亿
流通股本:1.20亿
量比:0.42
换手率:1.36%
股息:- -
股息率:- -
每股收益(TTM):-0.2325
每股收益(LYR):-0.2325
净资产收益率:-17.51%
总资产收益率:-21.82%
市净率:2.70
市盈率(LYR):-10.04

数据加载中...

2021/04/19

重要事件披露

8-K - Current report
2021/04/19

重要事件披露

8-K - Current report
2021/04/15

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/04/09

重要事件披露

8-K - Current report
2021/04/01

重要事件披露

8-K - Current report
2021/03/30

重要事件披露

8-K - Current report
2021/03/18

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/15

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/15

重要事件披露

8-K - Current report
2021/03/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/03/03

重要事件披露

8-K - Current report
2021/03/03

重要事件披露

8-K - Current report
2021/02/17

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/05

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals